In 1959 Elizabeth Hardwick complained that American book reviews were drowning in praise. Sixty-seven years later the complaint still stands, and a new Intellicurean essay asks a harder question: who is left to be wrong?
An empty chair above a flood of praise, made for the essay.
Why we’re pointing you there
Hardwick’s “The Decline of Book Reviewing” is the most famous complaint about soft criticism, and Who Is Left to Be Wrong begins by taking her at her word, numbers and all. From there it moves through Rosalind Krauss’s six-word claim about video, a BuzzFeed pledge borrowed from Thumper, and Edmund Wilson’s six-month public quarrel with Vladimir Nabokov. Then it opens the published guidelines of twelve leading review outlets to see what any of them actually says about judgment.
What we liked most is that the essay holds itself to its own standard. Its claim narrowed when the evidence came back against it, and it abandoned a count it couldn’t make honestly, saying so plainly at the end. Along the way it arrives at a sentence about favours that haven’t happened yet, and we haven’t stopped thinking about it.
The weight of a favour not yet done, made for the essay.
What is the largest art-history library in the world? The answer to this question depends of course on how you measure size, but an institution that might reasonably claim such a status is the RKD in The Hague. The RKD has for decades been a vast and invaluable library and archive, carefully nurtured by expert librarians and archivists (or ‘curators’ as they have long been described).
A new drawing by Édouard Manet
A newly identified drawing in a private collection of a crouching girl is a characteristic example of the red-chalk life studies that Édouard Manet made in the 1860s, influenced by his close study of Renaissance draughtsmanship in Florence. Although squared for transfer, the drawing has not yet been linked to any known composition by the artist.
Mistaken identities: Liotard’s 1762 portrait of Marie-Antoinette
A refined portrait by Jean-Étienne Liotard in the Musée d’art et d’histoire, Geneva, has long been identified as depicting Marie-Antoinette as a child. New research establishes, however, that it is a drawing of another member of the imperial Habsburg family and also reveals a hitherto unidentified likeness of Marie-Antoinette.
Historically, most human studies have involved male participants, and their findings were assumed to apply to women and children as well. Meanwhile, women’s health typically came up in the context of reproduction and childbearing, if at all. However, biomedical science has come a long way over the years, and it has become increasingly clear that there are sex-dependent differences in many diseases that do not involve reproduction and that occur at all ages. Across all areas of women’s health, including both reproductive and nonreproductive conditions, much remains to be learned about the underlying biology, effects of hormones and genetics, and potential therapeutic interventions.
Sex differences have traditionally been attributed to gonadal hormones, but accumulating evidence shows that sex chromosomes exert distinct, cell-autonomous effects on health, aging, and disease. XX and XY complements alter gene dosage, epigenetic programming, immune signaling, metabolism, and cellular stress responses, which shape aging and disease trajectories in women and men. This Review integrates mechanistic advances in sex chromosome biology—including escape from X chromosome inactivation, X reactivation, parent-of-X-origin, X-skew, X- and Y-linked gene functions, and Y loss—with aging, neurologic disease, immunity, cancer, and cardiometabolic disease. We highlight insights from mouse models, human studies, and emerging technologies that disentangle hormone-driven effects from chromosome-mediated effects and discuss translational implications for diagnostics, biomarkers, therapeutics, and clinical trial design, emphasizing the integration of sex chromosome biology into precision medicine.
Reframing menopause and menopause hormone therapy as opportunities for healthy aging
Menopause is an important biological transition with up to 72 symptoms that shapes aging trajectories across organs and encompasses ~40% of the female lifespan. Although menopause awareness is increasing, research on strategies for menopause symptom management and optimizing health in the postmenopausal period is lacking. This Review highlights that menopause characteristics, such as type, timing, and symptom burden, influence health outcomes and later-life disease risk. Similarly, menopause hormone therapy comes in >200 varieties that differ by dose, formulation of estrogens and progestogens, and timing, each with their own distinct risk-benefit profiles. These distinctions are often missed in the literature but have considerable repercussions for outcomes. Optimized menopause care necessitates a precision medicine approach that considers menopause symptoms, genetics, and previous hormone exposures.
Capt. Smit Machchhar, who was stabbed by his co-pilot midair between Dubai and Tel Aviv, said he “had to act” to prevent a crash despite serious injuries.